Ultrasis (LSE:ULT) Valuation Rank


What is Ultrasis Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Ultrasis Valuation Rank Related Terms

Ultrasis Business Description

Ultrasis PLC was incorporated in November 23, 1981. The Company through its subsidiary provides healthcare products and services provided via the medium of technology or face to face, that help people maintain, regain and improve their physical, psychological and social well-being. Its product includes Beating the Blues(r), GetFit Wellness, My Brain Solutions, The Relief Series, Drink & Drug Wise, Calm Workplace, and Optimise Me, Screenetics and Joggle.